Experts share here what they take away from CROI each year and why this meeting is so important in this space.

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

The Sunday Mail Dr Mombeshora Emmanuel Kafe In a move to ensure critical healthcare services continue uninterrupted, the ...

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

In 2020, the Conference on Retroviruses and Opportunistic Infections (CROI) was the first scientific conference to move from ...

Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development at 5 years of age compared with unexposed children, based on new data from ...

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...

Researchers from the HIV Prevention Trials Network (HPTN) presented results from the HPTN 094 ("INTEGRA") study at the 2025 ...

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...

Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...